Genezen, a leading gene therapy CDMO, has partnered with Elly’s Team, a foundation dedicated to accelerating the translation of medical research into treatments, for an AAV9 gene replacement therapy targeting Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech, and Seizures (NEDAMSS).